Neoplasms, Colorectal Completed Phase 1 Trials for Bevacizumab (DB00112)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00532909Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal CancerTreatment